 This systematic review and meta-analysis has demonstrated that commercially available AGRDTS have a high clinical accuracy in detecting SARS-CoV-2 infection in the first week of symptoms. This finding suggests that these tests could be useful in the early detection of SARS-CoV-2 infections, which could help reduce its spread. This article was authored by Lucas E. Brummer, Stefan Katzenslager, Mary Gatert, and others.